Achieve Life Sciences, Inc. (ACHV)
ACHV Stock Price Chart
Explore Achieve Life Sciences, Inc. interactive price chart. Choose custom timeframes to analyze ACHV price movements and trends.
ACHV Company Profile
Discover essential business fundamentals and corporate details for Achieve Life Sciences, Inc. (ACHV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Oct 1995
Employees
25.00
CEO
Richard A. Stewart
Description
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
ACHV Financial Timeline
Browse a chronological timeline of Achieve Life Sciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.18.
Earnings released on 12 May 2026
EPS came in at -$0.19 surpassing the estimated -$0.30 by +36.67%.
Earnings released on 24 Mar 2026
EPS came in at -$0.28 falling short of the estimated -$0.27 by -3.70%.
Earnings released on 6 Nov 2025
EPS came in at -$0.28 falling short of the estimated -$0.24 by -16.67%.
Earnings released on 7 Aug 2025
EPS came in at -$0.37 matching the estimated -$0.37.
Earnings released on 13 May 2025
EPS came in at -$0.37 matching the estimated -$0.37.
Earnings released on 11 Mar 2025
EPS came in at -$0.36 falling short of the estimated -$0.30 by -20.00%.
Earnings released on 7 Nov 2024
EPS came in at -$0.36 falling short of the estimated -$0.26 by -38.46%.
Earnings released on 13 Aug 2024
EPS came in at -$0.25 falling short of the estimated -$0.22 by -13.64%.
Earnings released on 9 May 2024
EPS came in at -$0.26 falling short of the estimated -$0.24 by -8.33%.
Earnings released on 28 Mar 2024
EPS came in at -$0.26 surpassing the estimated -$0.32 by +18.75%.
Earnings released on 9 Nov 2023
EPS came in at -$0.34 matching the estimated -$0.34.
Earnings released on 14 Aug 2023
EPS came in at -$0.43 falling short of the estimated -$0.41 by -4.88%.
Earnings released on 9 May 2023
EPS came in at -$0.50 surpassing the estimated -$0.65 by +23.08%.
Earnings released on 16 Mar 2023
EPS came in at -$0.83 surpassing the estimated -$0.90 by +7.78%.
Earnings released on 14 Nov 2022
EPS came in at -$1.35 falling short of the estimated -$1.10 by -22.73%.
Earnings released on 11 Aug 2022
EPS came in at -$1.08 falling short of the estimated -$0.79 by -36.71%.
Earnings released on 12 May 2022
EPS came in at -$0.80 surpassing the estimated -$0.82 by +2.44%.
Earnings released on 10 Mar 2022
EPS came in at -$0.76 falling short of the estimated -$0.73 by -4.11%.
Earnings released on 9 Nov 2021
EPS came in at -$0.71 surpassing the estimated -$1.09 by +34.86%.
Earnings released on 11 Aug 2021
EPS came in at -$1.53 falling short of the estimated -$1.23 by -24.39%.
ACHV Stock Performance
Access detailed ACHV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
